vimarsana.com
Home
Live Updates
PTAB Issues Final Written Decisions Finding Claims Of Regene
PTAB Issues Final Written Decisions Finding Claims Of Regene
PTAB Issues Final Written Decisions Finding Claims Of Regeneron's Aflibercept Patents Invalid - Patent
On November 9, 2022, the PTAB issued final written decisions in IPR2021-00880 and IPR2021-00881, filed by Mylan on two Regeneron patents related to aflibercept—U.S. Patent Nos. 9,254,338 and 9,669,069.
Related Keywords
West Virginia ,
United States ,
,
Northern District ,
Judge Kleeh ,
Big Molecule Watch ,
Mondaq ,
November 11 ,
022 Christopher Cassella ,
Intellectual Property ,
Patent ,